Click Here to return To Results

 

Tacrine (tetrahydroaminoacridine; THA) and Lecithin in Senile Dememtia of the Alzheimer Type:A Multicentre Trial BMJ 300:495-499, Chatellier,G.,et al, 1990 See this aricle in Pubmed Article Abstract Neither short term nor long term treatment with oral tacrine at dosages lower than 125 mg/day improves the symptoms of Alzheimer's disease. Moreover,these dosages may induce hepatitis(nine of 67 patients in this series).

Related Tags

(click to filter results - removes previous filter) adverse drug reaction Alzheimer's disease Alzheimer's disease,treatment of anticholinesterase dementia hepatitis lecithin liver disease tetrahydroaminoacridine treatment of neurologic disorder

Click Here to return To Results